Non-Postoperative Pain Management Epidemiology Summary

• According to DelveInsight’s analysis, the total incident cases of moderate-to-severe postoperative management were approximately ~91 million in the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan) in 2025.
• Non-Postoperative pain is highly prevalent across geographies, with injury prevalence ranging from ~10–12% in Europe and injury-related emergency burden accounting for ~12% of the US population annually, highlighting trauma as a major driver of acute pain episodes.
• Neurological non-Non-Postoperative pain conditions, such as migraine and severe headache, affect a significant proportion of the population, with prevalence estimated at ~6–16% across key markets, including the US, contributing substantially to chronic and recurrent pain burden.
• Evidence indicates that a substantial proportion of non-Non-Postoperative pain persists or recurs beyond the acute phase, with studies reporting ~62.7% of trauma patients experiencing pain up to 12 months post-injury, reinforcing the high transition risk from acute injury-related pain to longer-term pain conditions across the 7MM.

Non-Postoperative  Pain Management Epidemiology Forecast in the 7MM

• 2025 Incident Cases of Moderate-to-severe Non-Postoperative pain management: ~91 million
• Moderate-to-severe Non-Postoperative pain management Growth Rate (2026–2036): ~0.30% CAGR

DelveInsight's ‘Non-Postoperative  Pain Management Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the Non-Postoperative Pain management, historical and forecasted epidemiology, in the United States, EU4 (Germany, Spain, Italy, and France), and the United Kingdom, and Japan.

Non-Postoperative  Pain Management Understanding and Diagnosis Algorithm

Non-Postoperative  Pain Management Overview and Diagnosis

Non-postoperative acute pain management aims to reduce suffering, maintain function, and prevent chronic pain progression. It arises from trauma, infection, musculoskeletal injury, burns, dental, or medical conditions, and is driven by nociceptive inflammatory pathways, with perception influenced by individual biological and psychological factors. Poor control may lead to stress, sleep disturbance, delayed recovery, and chronic pain transition. Diagnosis is primarily clinical, based on pain history (onset, intensity, duration, location) and underlying cause, supported by tools such as VAS, NRS, VRS, Wong-Baker, and multidimensional scales like MPQ and BPI.

Further details are provided in the report...

Non-Postoperative Pain Diagnosis

Doctors diagnose the pain by discussing one’s symptoms, the intensity and location of pain, and the history of injury, surgery, or illness. Young patients may be asked to rate their pain intensity using the faces of the pain scale.

Additional diagnostic tests might include:

• Blood investigations (to assess infection or inflammation)
• X-rays (for fractures or structural injury)
• CT or MRI scans (for soft tissue, nerve, or internal injury assessment)
• Ultrasound imaging (for organ or soft tissue evaluation)
• Nerve conduction studies (for suspected neuropathic involvement)
• Dye-based imaging studies (for specific diagnostic clarification)

Further details are provided in the report...

Non-Postoperative  Pain Management Epidemiology

Key Findings from Non-Postoperative Pain Management Epidemiological Analysis and Forecast

• According to DelveInsight’s estimates, in 2025, the total number of incident cases of Moderate-to-severe Postoperative Pain in the 7MM was ~91 million.
• Across the 7MM, non-postoperative pain burden is strongly driven by a high volume of injury- and trauma-related cases, with the US alone reporting approximately 40 million injury-related emergency department visits (2020), accounting for about 12% of total population exposure.
• Trauma-related long-term pain remains highly prevalent, with evidence showing that ~62.7% of injured patients report persistent pain up to 12 months post-injury, highlighting a major source of chronic non-postoperative pain burden.
• Migraine and severe headache disorders, a major contributor to non-postoperative pain, affect a substantial proportion of the population, with prevalence ranging from ~6–16% across key markets, with a large proportion remaining undiagnosed or undertreated.

Scope of the Non-Postoperative  Pain Management Epidemiology Report

• The report covers a segment of a descriptive overview of Non-Postoperative  Pain Management, explaining its causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Report Insights

• Non-Postoperative Pain Management Patient Population Forecast

Report Key Strengths

• Epidemiology based (Epi based) Bottom up Forecasting
• 11-year Forecast
• Patient Burden Trends (by geography)

FAQs

• What are the disease risks, burdens, and unmet needs of Non-Postoperative pain management? What will be the growth opportunities across the 7MM concerning the patient population with Non-Postoperative pain management?
• What is the historical and forecasted Non-Postoperative pain management patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy Non-Postoperative  Pain Management Epidemiology Report

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives around the diagnostic challenges to overcome barriers in the future.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.